Pembrolizumab: Uses, Dosage, Side Effects & Warning - Drugs.com
WEBMar 26, 2024 · Pembrolizumab (Keytruda) is a type of immunotherapy used to treat cancers, including lung cancer, breast cancer, melanoma, head and neck cancer, and many more. Pembrolizumab works by helping your immune system to slow or stop the growth and spread of cancer cells in the body.
KEYTRUDA® (pembrolizumab) - Official Site
WEBLearn about KEYTRUDA® (pembrolizumab), an immunotherapy that works with your immune system to help fight certain cancers. Visit the patient website.
Pembrolizumab Injection: MedlinePlus Drug Information
WEBPembrolizumab injection is used alone or in combination with other chemotherapy medications to treat certain types of melanoma (a type of skin cancer), Merkel cell carcinoma (MCC; a type of skin cancer), and cutaneous squamous cell …
Pembrolizumab (Intravenous Route) Description and Brand Names - Mayo Clinic
WEBJul 1, 2024 · Pembrolizumab injection is used to treat urothelial cancer (a type of urinary tract cancer) that has spread throughout the body (metastatic) or cannot be removed by surgery (advanced). This medicine is used in combination with …
Pembrolizumab (Keytruda): Uses & Side Effects - Cleveland Clinic
WEBPembrolizumab injection. Pembrolizumab is a monoclonal antibody that treats certain types of cancer. The brand name of this medication is Keytruda®. A healthcare provider will give you this infusion in a hospital or clinic setting.
Pembrolizumab - Wikipedia
WEBPembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 Inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer.
DailyMed - KEYTRUDA- pembrolizumab injection, powder, …
WEBAug 7, 2024 · KEYTRUDA ® (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 2014. RECENT MAJOR CHANGES. INDICATIONS AND USAGE. KEYTRUDA is a programmed death receptor-1 (PD-1)-blocking antibody indicated: for the treatment of patients with unresectable or metastatic melanoma. (1.1)
Keytruda (pembrolizumab) dosing, indications, interactions, …
WEBIndicated for adjuvant treatment of adults with Stage IIB, IIC, or III melanoma following complete resection. 200 mg IV q3Weeks OR 400 mg q6Weeks. Continue until disease recurrence, unacceptable...
pembrolizumab intravenous: Uses, Side Effects, Interactions ... - WebMD
WEBFind patient medical information for pembrolizumab intravenous on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Keytruda: Uses, Dosage, Side Effects, Warnings - Drugs.com
WEBSep 9, 2024 · Keytruda (pembrolizumab) is an immunotherapy medication that may be used to treat at least 18 different types of cancer such as melanoma, non-small cell lung cancer (NSCLC), head and neck squamous cell cancer (HNSCC), classical Hodgkin Lymphoma, endometri.
Skip to content